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Herpesviruses are known for their persistent lifelong
latent infection, which is made possible by their vast
repertoire of immune-evasion strategies. We have
previously shown that a human cytomegalovirus
(HCMV) microRNA represses expression of the
stress-induced Natural Killer (NK) cell ligand, MICB,
to escape recognition and consequent elimination by
NK cells. Here, we show functional conservation
among diverse microRNAs derived from different
herpesviruses, including HCMV, Kaposi’s sarcoma-
associated herpesvirus (KSHV), and Epstein-Barr virus
(EBV), in their ability to directly target MICB mRNA and
reduce its expression. Although the various viral
microRNAs share no sequence homology, they are
functionally similar and target MICB at different yet
adjacent sites during authentic viral infection. The
finding that different herpesvirus microRNAs target
MICB indicates that MICB plays a pivotal role in the
clash between herpesviruses and humans.
INTRODUCTION
MicroRNAs (miRNAs) are 22 nt long noncoding RNAs that
posttranscriptionally regulate gene expression, mainly by
binding to the 30UTR of mRNAs. Such binding results in either
translational inhibition or in mRNA degradation, depending on
the degree of complementarity between themiRNA and its target
(Bartel, 2004, 2009). It is now known that all metazoan organisms
encode miRNAs, and recently miRNAs were identified in several
DNA viruses, many of them in human herpesviruses (Cullen,
2009; Pfeffer et al., 2004, 2005).
Kaposi’s sarcoma-associated herpesvirus (KSHV) and
Epstein-Barr virus (EBV) are both tumorigenic herpesviruses
that are capable of establishing a lifelong latent infection and are
associated with cancers of epithelial, endothelial, and lymphoid
origin (Cesarman, 2002a, 2002b). KSHV, EBV, and also human
cytomegalovirus (HCMV) encode numerous miRNAs (Cai and
Cullen, 2006; Cullen, 2009; Grey et al., 2005; Pfeffer et al.,
2004, 2005), and all three viruses are notorious for their diverse376 Cell Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier Istrategies of evading host immune responses (Jonjic et al.,
2008; Powers et al., 2008).
The identification of miRNA targets is a challenging task. First,
miRNAs require only limited complementarity for their 30UTR
binding and gene modulation (Brennecke et al., 2005; Grimson
et al., 2007). Second, although full seed (nucleotides 2–7 in the
50 end of the miRNA) complementarity is generally needed, it is
not always essential (Stern-Ginossar et al., 2007; Yekta et al.,
2004). With regard to viral miRNAs, target prediction is further
complicated by the notion that both cellular and viral targets
should be considered, and because viruses show poor
sequence conservation (Gottwein and Cullen, 2008), rendering
the use of today’s available algorithms problematic (Bartel,
2009). Indeed, only a few viral and cellular targets were identified
for KSHV, EBV, and HCMV miRNAs, and the function of only
a limited number of them was verified experimentally (Cullen,
2009; Gottwein and Cullen, 2008).
Natural Killer (NK) cells play a crucial role in the elimination of
virus-infected and transformed cells (Arnon et al., 2006; Glas
et al., 2000). The execution of the direct killing is a result of
a change in the balance of signals, delivered from activating
and inhibitory receptors (Arnon et al., 2006; Glas et al., 2000).
One of the most powerful activating receptors is NKG2D (Raulet,
2003). This dominant killer receptor recognizes stress-induced
molecules such as MICA, MICB, and ULBP1–4, which are upre-
gulated at the cell surface due to ‘‘insults’’ such as viral infec-
tions, tumor transformation, heat shock, andDNAdamage (Bois-
sel et al., 2006; Groh et al., 1996). Thus, it would be beneficial for
a virus to downregulate the expression of these ligands in order
to avoid immune cell attack. Indeed, we have recently shown
that an HCMV miRNA, miR-UL112, downregulates MICB
expression, thus leading to the reduced killing of infected cells
by NK cells (Stern-Ginossar et al., 2007, 2008).
In light of the similarities exhibited by HCMV, KSHV, and EBV,
both in their life cycle and in their in vivo targets (Faulkner et al.,
2000; Jenner and Boshoff, 2002; Sampaio et al., 2005), and
because such an effort is made by HCMV to prevent MICB
expression, we hypothesized that MICB expression might also
be manipulated by the miRNAs of KSHV and EBV.
Here, by using a functional approach and basic bioinformatics
tools, we demonstrate a functional conservation among different
herpesviruses, aimed at reducing the expression of a cellular
immune gene. By using their miRNAs, KSHV, EBV, and HCMV
employ a uniform strategy to exclusively target the host stressnc.
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MICB Is the Target of Various Viral MicroRNAsFigure 1. KSHV and EBV MiRNA-Mediated
Translational Repression of MICB
(A) FACS analysis of ULBP3 and of MICB expres-
sion by RKO cells transduced with lentivirus
encoding either the KSHV miRNA cluster or the
EBV pri-miR-BART2. The gray empty histogram
represents the staining of ULBP3 or of MICB in
the viral miRNA-transduced cells. The black
empty histogram represents the staining of cells
transduced with a control miRNA (miR-K12-12).
The filled gray histogram represents the staining
of the secondary mAb only.
(B) Western blot analysis of MICB protein levels
expressed by the cells stained in (A). Quantifica-
tion of relative intensity was performed by ImageJ
software.
(C) Quantitative real-time PCR analysis of the
MICB mRNA levels in the transduced RKO cells.
Relative mRNA abundance is shown as a
percentage of the level of HPRT mRNA (encoding
hypoxanthine guanine phosphoribosyltransfer-
ase), and error bars (SD) are derived from tripli-
cates. MiR-K12-12 served as negative control.ligand MICB, which consequently facilitates the escape of the
infected cells from NKG2D-mediated immune recognition and
killing. This evolutionarily conserved strategy emphasizes the
critical and the broad role of MICB in the host antiviral immune
response.
RESULTS
KSHV and EBV Downregulate MICB Expression via
a MiRNA-Based Translational Repression Mechanism
Herpesviruses are well known for their persistent latent infection
and for the diverse strategies they employ to evade host immune
attack. In light of our recent findings (Stern-Ginossar et al., 2007)
and the knowledge that herpesviruses use common strategies
for immune evasion, we hypothesize that the strategy of using
a miRNA to target a host immune gene might also be conserved
among different herpesviruses.
The miRNAs of KSHV and of EBV are located in clusters. All of
the KSHV miRNAs are encoded from a single cluster located in
the latency-associated region (Cai et al., 2005; Pfeffer et al.,
2005; Samols et al., 2005), while most EBVmiRNAs are encoded
from two separate clusters (the BHRF and the BART clusters)
(Landgraf et al., 2007; Pfeffer et al., 2004, 2005). Two other
EBV miRNAs, miR-BART2-5p and -3p, are encoded from
a singular hairpin structure and are separated from the above
clusters (Pfeffer et al., 2004).
Since it is known that sequences of herpesvirus miRNAs are
generally poorly conserved (Gottwein and Cullen, 2008), we
decided to use both a bioinformatic approach and a functional
approach to search for miRNAs in KSHV and EBV that will target
MICB. Using the website RNAhybrid (http://bibiserv.techfak.
uni-bielefeld.de/rnahybrid/submission.html), we scanned all of
the KSHV and EBV miRNAs for a potential binding site in
MICB 30UTR that contains a full seed match with Watson-Crick
base-pairing. Our suspected candidates were a KSHV miRNA,
named miR-K12-7, and an EBV miRNA, named miR-BART2-
5p. To test whether these miRNAs could indeed downregulateCelMICB, we cloned part of the KSHV miRNA cluster (11 out of
14 miRNAs in the miR-K12 cluster) and the EBV pri-miR-
BART2 (encoding for two miRNAs, -5p and -3p) into lentiviral
vectors. RKO cells that endogenously express MICB were
transduced with these lentiviruses and analyzed by FACS for
the expression of MICB and another NKG2D ligand, ULBP3,
as a control. As can be seen in Figure 1A, no change was
observed in the expression of ULBP3 (Figure 1A, upper), yet
a substantial decrease was observed in that of MICB (Fig-
ure 1B, lower). To further confirm the specificity of the MICB
downregulation and to address the mechanism involved, we
performed a western blot analysis for the levels of MICB
protein in the transduced RKO cells (Figure 1B). In agreement
with the FACS staining data, the MICB protein levels
were reduced in both the KSHV miRNA cluster and the EBV
pri-miR-BART2-transduced cells (Figure 1B). The pri-miR-
BART2-transduced cells showed a reduction of 60% in
MICB protein levels, and the miR-K12-cluster-transduced cells
showed a reduction of 40% (Figure 1B). Next, we tested the
effect these miRNAs have on the mRNA level of MICB by per-
forming quantitative real-time PCR analysis. As can be seen in
Figure 1C, these miRNAs have no effect on the level of MICB
mRNA. Thus, miRNAs of both KSHV and EBV modulate MICB
expression by affecting its protein levels but not its mRNA
levels.
In order to elucidate whichmiRNAs of themiR-K12 cluster and
of the pri-miR-BART2 mediate the translational repression of
MICB, we cloned each of them individually into a lentiviral
construct. Each of these constructs contained a viral miRNA
and a GFP cassette, each under the regulation of a different
promoter. Using these constructs, we transduced 293T and
RKO cell lines with the various KSHV miRNAs. The 293T cell
line was stained for MICA expression, as it expresses only little
amounts of MICB, and the RKO cell line was stained for MICB,
as it expresses little amounts of MICA (Figures 2A and 2B,
respectively). Little or no change in MICA levels was observed
in all transduced cells (Figure 2A). However, MICB expressionl Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier Inc. 377
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MICB Is the Target of Various Viral MicroRNAsFigure 2. MiR-K12-7 and MiR-BART2-5p Are the Viral MiRNAs that Mediate MICB Downregulation
(A) FACS analysis of MICA expression by 293T cells transducedwith lentivirus encoding the above indicated KSHVmiRNA. The gray empty histogram represents
the staining of MICA expression by the transduced cell. The black empty histogram represents the staining of miR-K12-1, which was used as a control. The filled
gray histogram represents the staining of the secondary mAb only.
(B) FACS analysis ofMICB expression byRKOcells transducedwith lentivirus encoding the indicatedKSHVmiRNA. The gray empty histogram represents the stain-
ing of MICB expression by the transduced cell. The black empty histogram represents the staining of miR-K12-1 or miR-K12-2miRNAs that were used as controls.
The filled gray histogram represents the staining of the secondary mAb only. The red histogram shows the MICB downregulation mediated by miR-K12-7.378 Cell Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier Inc.
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MICB Is the Target of Various Viral MicroRNAswas dramatically reduced by one of the KSHV miRNAs, named
miR-K12-7 (Figure 2B, red histogram).
The EBV miR-BART2-5p was also cloned into the lentiviral
construct. HeLa cells were transduced with miR-BART2-5p
and were stained for MICA and MICB expression. As observed
for miR-K12-7, little or no change in MICA expression was
observed (Figure 2C, upper panel). However, there was
a substantial decrease in MICB expression (Figure 2C, lower
panel, red histogram). Similar results were obtained with the
293T (for MICA, which was not downregulated) and RKO (for
MICB, which was downregulated) cells (data not shown). In
order to verify that the effects observed are not due to improper
processing of the miRNA from the lentiviral constructs, we
transfected RKO cells with RNA duplexes of the mature form
of miR-K12-7 and of miR-BART2-5p. As can be seen in
Figure 2D and in agreement with the above results (Figure 1
and Figures 2A–2C), there was a significant reduction in MICB
expression following the transfection of both duplexes. Thus,
we can conclude that, in addition to HCMV (Stern-Ginossar
et al., 2007), both KSHV and EBV encode a miRNA that down-
regulates MICB.
MiR-K12-7 and MiR-BART2-5p Directly Bind
to the 30UTR of MICB
To test whether these two viral miRNAs directly bind to the 30UTR
of MICB, we performed a dual luciferase reporter assay. Initially,
we tested miR-K12-7 for this ability. To this end, we generated
two Firefly luciferase constructs, one containing the wild-type
30UTR of MICB and the second containing a mutated 30UTR
(named mut-K) (Figure 3A). These constructs were transiently
transfected into RKO cells that had been transduced with
miR-K12-7 or with a control miRNA. As can be seen in Figure 3B,
a decrease in luciferase activity was observed only in cells ex-
pressing miR-K12-7 and the wild-type 30UTR, while mutations
in the 30UTR abolished this observed effect.
In the initial scan performed to detect EBV miRNAs that might
bind to MICB 30UTR, we identified two potential binding sites for
miR-BART2-5p. These binding sites were named E1 and E2
(Figure 3C). To test whether miR-BART2-5p-mediated repres-
sion is the result of direct binding to the 30UTR of MICB, we again
performed a dual luciferase reporter assay. To this end, we
generated two double mutations in theMICB 30UTR, one located
at the seed sequence of the E1 binding site and the second at
the seed sequence of the E2 binding site (Figure 3D). The
two different constructs were then transiently transfected into
RKO cells expressing either miR-BART2-5p or a control
miRNA. A significant decrease in luciferase activity was
observed in RKO cells expressing miR-BART2-5p (Figure 3E),
indicating that the 30UTR of MICB contains a binding site for
miR-BART2-5p. Mutations in the E2 seed had no effect on the
repression activity. However, mutations performed in the E1
site caused a significant reversion in the repression of luciferase
activity (Figure 3E).CellThus, we identified the specific binding sites of miR-K12-7 and
of miR-BART2-5p in the 30UTR of MICB and can now consider
the strategy of MICB miRNA targeting as a common trait of
human herpesviruses.
Reduced MICB Expression Mediated by MiR-K12-7
andMiR-BART2-5p Leads to ReducedKilling byNKCells
To study the functional consequences of the reduced MICB
expression, mediated bymiRK12-7 andmiR-BART2-5p, we per-
formed NK cytotoxicity assays on RKO cells transduced with
miR-K12-7, miR-BART2-5p, or a control miRNA. In agreement
with the efficient reduction of MICB expression (Figure 2B),
a significant reduction of NK-mediated RKO killing was observed
when miR-K12-7 was present in the cells (Figure 4A, gray
columns). This reduction in the killing by NK cells resulted from
reduced MICB expression, as killing of all cells was equivalent
when the NKG2D interactions were blocked (Figure 4A, white
columns). Reduced killing of RKO cells expressing miR-
BART2-5p was also observed (Figure 4B, gray columns). This
reduced killing mediated by miR-BART2-5p was statistically
significant; however, it was less pronounced than that observed
with miR-K12-7. Indeed, the reduction in MICB expression in
cells expressing miR-BART2-5p was also less pronounced
(compare Figure 2B to Figure 2C). As in the case of miR-K12-7,
the reduced miR-BART2-5p-mediated killing was also due to
NKG2D recognition, as killing of all cells was similar when the
NKG2D recognition was blocked (Figure 4B, white columns).
MiR-K12-7 and MiR-BART2-5p Mediate Immunoevasion
during Authentic Viral Infection
To demonstrate the viral miRNA-mediated strategy of downre-
gulating MICB during actual infection, we tested whether
MICB is indeed targeted by these two viral miRNAs during
authentic viral infection. Initially, in order to verify the expression
of the viral miRNAs in KSHV-infected and EBV-infected cell lines
(BCBL1 and 721.221, respectively), we performed quantitative
real-time PCR assays with custom-designed miRNA-taqman
primers. Indeed, the presence of each viral miRNAwas detected
in the relevant cell line (Figure 5A). Next, we designed an antiviral
miRNA sponge for each viral miRNA, as recently described
(Ebert et al., 2007). These miRNA sponges ‘‘absorb’’ the rele-
vant miRNA, as they contain multiple adjacent binding sites
for the miRNA of interest, thus functioning as ‘‘decoy tran-
scripts,’’ and consequently prevent the downregulation of the
original targets. The antiviral miRNA sponges were cloned into
a lentiviral vector containing a GFP cassette that enables the
monitoring of transduction efficiency. BCBL1 and 721.221 B
cell cell lines were transduced with the antiviral miRNA sponges
and, as can be seen by FACS analysis in Figure 5B, transduction
of these cell lines with the relevant antiviral miRNA sponge re-
sulted in a specific increase in the expression of MICB, which
was not observed with regard to MICA. Since MICA and MICB
are stress-induced ligands, we further established the(C) FACS analysis of MICB andMICA expression in HeLa cells transducedwithmiR-BART2-5p. The gray empty histogram represents the staining ofmiR-BART2-
5p, the red histogram shows the MICB downregulation, the black empty represents the control miRNA, and the filled gray represents the secondary mAb only.
(D) FACS analysis of RKO cells transfected with RNA duplexes of the mature viral miRNAs. The gray empty histogram represents the staining of cells transfected
with the RNA duplex. The black empty histogram represents the staining of mock transfection. The filled gray histogram represents the staining of the secondary
mAb only.Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier Inc. 379
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MICB Is the Target of Various Viral MicroRNAsFigure 3. MiR-K12-7 and MiR-BART2-5p Directly Bind to the 30UTR of MICB
(A) Alignments of the predicted binding site of miR-K12-7 to the MICB 30UTR (upper) and of the mutated site in the MICB 30UTR (named mut-K, lower). The seed
region is underlined, and the location of the site is noted in brackets.
(B) The translation repression of luciferase reporter gene activity mediated by miR-K12-7. The figure demonstrates relative luciferase activity after transfection of
the indicated reporter plasmids into RKO cells expressing either miR-K12-7 (white) or GFP as control (gray). Firefly luciferase activity was normalized to Renilla
luciferase activity and then normalized to the average activity of the control reporter. Shown are mean values ± SD. Statistically significant differences are
indicated (*p < 0.015, **p < 0.0008, by one-tailed t test). Error bars (SD) are derived from triplicates.
(C) Alignments of two potential binding sites of miR-BART2-5p to the 30UTR of MICB (named E1 and E2). The seed region is underlined, and their location is noted
in brackets.
(D) Alignments of miR-BART2-5p to the two mutated sites in the 30UTR of MICB (named mut-E1 and mut-E2).
(E) The translation repression of luciferase reporter gene activity mediated by miR-BART2-5p. The figure demonstrates relative luciferase activity after transfec-
tion of the indicated reporter plasmids into RKO cells expressing eithermiR-BART2-5p (white) or GFP as control (gray). Firefly luciferase activity was normalized to
Renilla luciferase activity and then normalized to the average activity of the control reporter. Shown are mean values ± SD. Statistically significant differences are
indicated (*p < 0.003, **p < 0.0008, by one-tailed t test). Error bars (SD) are derived from triplicates.specificity of these sponges using two different approaches.
First, we transduced BCBL1 and 721.221 cells with additional
irrelevant sponges (anti-miR-K12-8 and anti-miR-BART4) and
observed that these sponges had no effect on the expression
of either MICA or MICB (Figure S1). Second, we performed
a dual luciferase assay using the relevant sponges. 293T cells
transduced with miR-K12-7, miR-BART2-5p, or a control
miRNA were also transduced with either the relevant sponge
for each viral miRNA or an irrelevant sponge. The 293T cells
were next transiently transfected with a Firefly luciferase
construct fused to the 30UTR of MICB, and its relative activity
was measured and normalized, as described in the Experi-
mental Procedures. As demonstrated by Figure 5C, the effect
of the relevant sponges was specific, as the repression of lucif-
erase activity by the viral miRNAs was abolished only in their
presence.380 Cell Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier InTo further establish the importance of reducing MICB expres-
sion during authentic viral infection, we performed NK killing
assays on the above cells with and without the specific sponges,
aswasdescribedabove. In agreementwith thesponge-mediated
upregulation of MICB, observed in cells infected with KSHV and
EBV (Figure 5B), cells expressing the relevant sponge showed
increased NK killing (Figure 6). A more substantial enhancement
in the NK killing was observed in the BCBL1 sponge-transduced
cells than that observed in the 721.221 sponge transduced cells.
This is probably because BCBL1 cells express very low amounts
of MICB before sponge activity, whereas 721.221 cells express
relatively high amounts of MICB prior to transduction, and thus
the level of 721.221 killing could only be modestly increased.
Thus, during authentic viral infection, the two viral miRNAs,
miR-K12-7 and miR-BART2-5p, specifically downregulate
MICB expression to avoid attack by immune cells.c.
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MICB Is the Target of Various Viral MicroRNAsFigure 4. The MICB Downregulation by
MiR-K12-7 and MiR-BART2-5p Results in
Reduced NKG2D-Mediated Killing
(A and B) Cells expressing miR-K12-7 or miR-
BART2-5p exhibit reduced NK killing. Bulk NK
cells were preincubated either with anti-NKG2D
mAb (white) or with isotype control mAb (gray).
Labeled RKO cells expressing miR-K12-7 (A),
miR-BART2-5p (B), or control miRNA (miR-K12-
12) (A and B) were then added and incubated for
5 hr. Shown are mean values ± SD. Statistically
significant differences are indicated (*p % 0.03,
by one-tailed t test). Error bars (SD) are derived
from triplicates.MICA Might Have Escaped Targeting by Viral MiRNAs
So far, we have demonstrated that MICB and not MICA is the
primary target for HCMV, KSHV, and EBV miRNA regulation.
We next wondered why MICA is not targeted by the viral
miRNAs. As will be discussed later, one of the possible answers
to this question is that MICA had escaped the viral miRNA
targeting. We therefore scanned the 30UTR of MICA for potential
binding sites for the various viral miRNAs and identifiedCella sequence that is extremely similar to the MICB binding site
of miR-BART2-5p. This sequence differs in only two additional
nucleotides from that present in the MICB 30UTR (Figure 7A).
Moreover, the location of the sequence in the MICA 30UTR, rela-
tive to the beginning of the 30UTR, corresponds with that in MICB
30UTR. No such sequence was identified for miR-K12-7, as the
30UTR of MICA is truncated exactly at the predicted miR-K12-7
binding site (Figure 7A). This observation, combined with theFigure 5. MiR-K12-7 and MiR-BART2-5p
Are Expressed and Are Functional during
Authentic Viral Infection
(A) Quantitative real-time PCR analysis of viral
miRNA expression using custom-designed
Taqman RT primer and real-time PCR probe. The
KSHV-infected BCBL1 cell line was assayed for
the expression of miR-K12-7. The EBV-trans-
formed 721.221 cell line was assayed for the
expression of miR-BART2-5p. The cell lines
served as negative controls for each other. RKO
cells transduced with the relevant lentivirus were
used as positive controls. Error bars (SD) are
derived from triplicates.
(B) FACS analysis of the expression of MICA and
MICB by KSHV-infected and EBV-infected cell
lines. Left side shows staining of BCBL1 cells
transduced with an anti-miR-K12-7-sponge (gray
empty histogram) or with anti-miR-BART2-5p
sponge as control (black empty histogram). The
filled gray histogram is of secondary mAb staining
only. Right side shows staining of 721.221 cells
transduced with an anti-miR-BART2-5p sponge
(gray empty histogram) or with anti-miR-K12-7
sponge as control (black empty histogram). The
filled dark gray histogram is the staining of MICB
expression by parental 721.221. The filled gray
histogram is of secondary mAb staining only.
(C) The specific effect of the antiviral miRNA
sponges was tested in a dual luciferase reporter
assay. 293T cells were transduced with miR-
K12-7 (left) or with miR-BART2-5p (right). In addi-
tion, each 293T cell was transduced with either
a relevant sponge (white) or an irrelevant sponge
(gray). Firefly luciferase activity was normalized
to Renilla luciferase activity and then normalized
to the average activity of the control reporter.
Shown are mean values ± SD. Statistically signifi-
cant differences are indicated (*p < 0.006, by
one-tailed t test). Error bars (SD) are derived
from triplicates.Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier Inc. 381
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MICB Is the Target of Various Viral MicroRNAsFigure 6. Functional Conservation of the
EBV and KSHV Viral MiRNAs during
Authentic Infection
(A and B) The NK cell killing of the sponge-trans-
duced BCBL1 (A) and 721.221 (B) cell lines.
Open circle indicates cells transduced with
a control vector; filled triangles indicate cells trans-
duced with the relevant antiviral miRNA sponge.
Both BCBL1 and 721.221 cells transduced with
the antiviral miRNA sponge exhibit an increase in
NK killing. Shown are mean values ± SD. Statisti-
cally significant differences are indicated (*p %
0.03, **p % 0.003, by one-tailed t test). Error
bars (SD) are derived from triplicates.fact that miR-UL112 also has an almost identical site in MICA,
which is modestly influenced by miR-UL112 (Stern-Ginossar
et al., 2007), suggests that MICA was successful in escaping
the viral miRNA targeting, either by mutating particular nucleo-382 Cell Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier Intides and/or shortening its 30UTR. To strengthen this hypothesis,
we mutated the miR-BART2-5p site in the MICA 30UTR to that
present in the MICB 30UTR and then fused it to the Firefly lucif-
eraseORF.We performed a dual luciferase assay by transfectingFigure 7. MICA Escaped Viral MiRNA Tar-
geting by Mutating and Severing Its 30UTR
(A) The alignments between each of the three viral
miRNAs and the 30UTR of MICB (left) or of MICA
(right). Noted in brackets is the location of the
binding site with respect to the beginning of the
30UTR, and in red are the nucleotides, which
appear in the MICA binding site but not in the
MICB binding site.
(B) When mutated to the miR-BART2-5p-MICB
binding site, MICA 30UTR is repressed. The figure
demonstrates the relative activity of a Firefly lucif-
erase when fused to a mutated MICA 30UTR.
Firefly activity was normalized as stated. Shown
are mean values ± SD. Statistically significant
differences are indicated (*p % 0.002, by one-
tailed t test). Error bars (SD) are derived from
triplicates.
(C) A schematic representation of the 30UTR of
MICA (upper) and MICB (lower) and of the target
sites of the three herpesvirus miRNAs: HCMV
(miR-UL112) (orange), EBV (miR-BART2-5p)
(green), and KSHV (miR-K12-7) (red).c.
Cell Host & Microbe
MICB Is the Target of Various Viral MicroRNAsRKO cells transduced with either miR-BART2-5p or a control
miRNA. As can be seen in Figure 7B, the wild-type 30UTR of
MICA shows little or no repression of luciferase activity, while
the mutated MICA 30UTR (converted to MICB) repressed it
dramatically. Importantly, the gained MICA-to-MICB repression
was similar to the repression observed with the wild-type MICB
30UTR.
DISCUSSION
Weprovide in this manuscript an example of a functional conser-
vation among various herpesvirus miRNAs to downregulate
a host immune gene. We show that KSHV and EBV as well as
HCMV (Stern-Ginossar et al., 2007) contain miRNAs that, in
a specific manner, downregulate the stress-induced immune
molecule MICB during authentic infection to avoid NK cell killing.
Although similar physiological roles are assigned to both MICB
andMICA, onlyMICB is efficiently targeted by all of these herpes-
virus miRNAs. For this, we can propose two reasons: (1) MICA
has evolved to escape the targeting of herpesvirus miRNAs,
and (2)MICB is of greater importance in the host antiviral immune
responses. In our view, these two options are not contradictory,
but rather together underline the critical role MICB possesses.
Indeed, one outstanding difference between the two stress-
induced molecules is the length of their 30UTRs. The 30UTR
of MICB is 7 times longer than that of MICA (1213 nt versus
174 nt, respectively) (Figure 7C). This observation might favor
the possibility that MICA has evolved to escape the manipula-
tions by herpesviruses by severing its 30UTR. One example, sup-
porting this hypothesized strategy, is the existence of a certain
MICA allele, MICA*008, which contains a truncated transmem-
brane domain and cytoplasmic tail; therefore it can not be tar-
geted for sequestration by the HCMV protein UL142 (Chalupny
et al., 2006). Furthermore, two possible target sites in MICA
30UTR were observed for the HCMV and EBV miRNAs. Remark-
ably, these sites are located at similar positions in comparison to
the 30UTR of MICB. With regard to KSHV miRNA, no such site
was found in the MICA 30UTR, probably due to its short length
(Figures 7A and 7C). Thus, it seems as if MICA might have
escaped the viral miRNA targeting by both shortening its
30UTR and mutating essential nucleotides crucial for the binding
sequences of the viral miRNAs (Figures 7A and 7C). Indeed, as
demonstrated in Figure 7B, converting the miR-BART2-5p-
MICA binding site to that present in MICB enabled its repression
by miR-BART2-5p.
It is also possible that MICB, but not MICA, is the target of the
viral miRNAs, as it might be the major stress immune protein that
is expressed in vivo after infection. Indeed, B cells (such as the
721.221 cells shown here) and endothelial cells, which are
targets for all three viruses, express MICB but not MICA. In addi-
tion, upon stress, MICB displays amore substantial upregulation
thanMICA (Spies, 2008). Thus, the viral miRNAs target MICB but
not MICA because MICB might be of greater importance in vivo.
Finally, this differential regulation of MICA and MICB might
enable the ongoing coexistence of the herpesviruses and their
hosts, which might be beneficial both for the virus and for the
host (Barton et al., 2007).
Another surprising observation is that even though all three
herpesviruses share a common target, their miRNAs do notCelshare sequence homology, and their binding sites in the 30UTR
ofMICB are therefore also different (Figure 7C). This might repre-
sent both coevolution and individual convergent evolution of
various herpesviruses to target a single host immune gene.
Thus, mutation of one binding site by the host will interfere with
the binding of only one viral miRNA, without affecting the MICB
downregulation mediated by the others. This strategy would be
most effective in cases of coinfection (as occurs in some B cell
lymphomas), in which elimination of the binding site of one virally
encoded miRNA will not affect the end result: reduced expres-
sion of MICB. Interestingly, all sites of the viral miRNAs are
located in close proximity to each other, at the beginning of
the 30UTR of MICB (Figure 7C). This observation is in agreement
with other reports demonstrating that cellular miRNA targeting is
more efficient if the sites are located at either ends of the 30UTR
(Grimson et al., 2007).
A final noteworthy observation is that the similarity in the ability
to regulate MICB expression between KSHV and HCMV
expands beyond the posttranscriptional miRNA pathway. Both
herpesviruses not only encode miRNAs that downregulate
MICB but also produce proteins for that same purpose. These
proteins, K5 (KSHV) and UL16 (HCMV), are less specific
compared with the viral miRNAs and mediate the sequestration
not only of MICB, but also of other NKG2D ligands (Dunn et al.,
2003; Thomas et al., 2008). It is yet unknownwhether EBV shares
this strategy. However, this combined approach of viral proteins
and viral miRNAs to downregulate MICB emphasizes the role it
plays in the antiviral response against all three viruses in vivo.
MiRNAs are attractive candidates for virally mediated host
gene regulation due to their small size and their lack of immuno-
genicity. Hence, it is not surprising that viruses causing lifelong
latency, such as herpesviruses, have been found to encode
miRNAs. The fact that all three herpesviruses encode miRNAs,
which share MICB as a cellular target, implies that MICB plays
a crucial role in the long period of coexistence between herpes-
viruses and the human host.
EXPERIMENTAL PROCEDURES
Lentiviral Constructs, Production, and Transduction
The miR-K12 cluster and a fragment of 400 nt surrounding the pri-miR-BART2
were amplified from genomic DNA fromBCP1 and 8866 cell lines, respectively.
The following primers were used: miRK cluster, 50 CGGGATCCCGCCCAC
TGACGTGGATGCCCTAATG 30 and 50 CGGAATTCCGGGGTTAGCCACCCAT
TTCCC 30; pri-miR-BART2, 50 CGCGGATCCGTCATGCCGCTGAGGAAGG
CG 30 and 50 CCGGAATTCGTGCAGGGGGCTCGGCATTCC 30. The amplified
DNA fragments were inserted into the lentiviral vector SIN18-pRLL-hEFIap-
EGFP-WRPE (Xu et al., 2001) instead of the eGFP cassette using the BamHI
and EcoRI restrictions. RNA artificial hairpins that function as orthologs of
pre-miRNA hairpins were generated by using the pTER vector (van de Weter-
ing et al., 2003). Two complementary specific oligonucleotides (see Supple-
mental Data) were annealed, phosphorylated using T4 polynucleotide kinase
as was previously described (van de Wetering et al., 2003), and inserted into
the pTER vector. The artificial hairpin and H1 RNA polymerase III promoter
were excised from the vector and cloned into the lentiviral vector SIN18-
pRLL-hEFIap-EGFP-WRPE. The lentiviral vector contains GFP, thus allowing
the simultaneous expression of both reporter GFP and miRNA. Similarly,
sponge constructs were generated by annealing oligonucleotides, phosphor-
ylating, and inserting them into the pcDNA3 vector (Invitrogen). Then they were
excised and cloned into the lentiviral vector SIN18-pRLL-hEFIap EGFP-WRPE
(Xu et al., 2001), downstream to the GFP cassette. Each sponge consists of six
adjacent binding sites for the relevant viral miRNA, separated by a 4 nt spacer.l Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier Inc. 383
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GCCAGCUGUUGGGAUCA. anti-miR-BART2-5p: GCAAGGGCGACCGAGAA
AAUA. anti-miR-K12-8: CGTGCTCTCTGTGCGCGCCTA. anti-miR-BART4:
AGCACACCAGGTGATCAGGTC. Lentiviral viruses were produced by tran-
sient three-plasmid transfection as described (Stern-Ginossar et al., 2007).
The pMD.G envelope expression cassette (3.5 mg), the gag-pol packaging
construct (6.5 mg), and the relevant vector construct (10 mg) were transfected
using the LT1 transfection reagent (Mirus Bio LLC, Madison, WI). Two days
after transfection, the soups containing the viruses were collected and filtered.
Cytotoxicity Assay and NK Cell Preparation
The cytotoxic activity of NK cells against various targets was assessed in 5 hr
35S release assays as described (Mandelboim et al., 1996). The final concen-
tration of the blocking antibodies was 2.5 mg/ml. NK cells were isolated from
peripheral blood using the Human NK Cell Isolation Kit and an autoMACS
(Miltenyi Biotec) according to the manufacturer’s instructions.
Cells and Antibodies
The 293T, RKO, HeLa, 721.221, and BCBL1 cell lines were used. Anti-MICA,
anti-MICB, anti-ULBP3, and anti-NKG2D antibodies were all purchased from
R&D Systems (Minneapolis). The anti-CD99 (12E7), used as an isotype control,
is a kind gift of A. Bernard.
RNA Duplex and Transfection
The miR-K12-7 and miR-BART2-5p mature miRNA duplexes were obtained
from Sigma. MiR-K12-7 duplex 50 arm: 50-CGCCAGCAACAUGGGAUCCCU-
30; 30 arm: 30-UCGCGGUCGUUGUACCCUAGU-50. MiR-BART2-5p duplex 50
arm: 50-AAGGGCGAAUGCAGAAAAUCCU-30; 30 arm: 30-CGUUCCCGCUUA
CGUCUUUUAU-50. RKO cells were plated in 6-well plates, to be 70%–80%
confluent the next day. Cells were transfected with 75 pmole of the appropriate
RNA duplex and stained 24 hr later. Twomicroliters of LT1 transfection reagent
(Mirus) was used per well.
Western Blot
Cells were counted and collected. Equal volumes of samples were run on 10%
Tris-HCl gels, which were then transferred onto nitrocellulose and then
incubated overnight with 5% milk. Membranes were incubated for 2 hr with
1 mg/ml anti-MICB mAb (R&D Systems), washed with 0.4% Tween in PBS,
and then incubated for 0.5 hr with an anti-mouse-HRP secondary antibody
(Jackson Laboratory).
Quantitative Real-Time PCR
For quantitative real-time PCR analysis, cDNA was produced from RKO cells
transduced with the miR-K12 cluster, pri-miR-BART2, and a control miRNA.
Total RNA was isolated with TRI Reagent (Sigma). Then it was reverse tran-
scribed with Moloney murine leukemia virus reverse transcriptase (Invitrogen)
and random primers (Roche). DNA was amplified with specific primers as
described (Stern-Ginossar et al., 2008) and a DyNAmo SYBR Green qPCR
kit (Finnzymes) on an ABI PRISM 7500 Real-Time PCR system (Applied Bio-
systems). Quantitative real-time PCR of mature miRNA was done with
custom-designed mature miRNA-taqman primers and probes (Applied Bio-
systems). Total RNA was isolated with TRI Reagent (Sigma) and reverse tran-
scribed with specific taqman primers. DNA was amplified on an ABI PRISM
7500 Real-Time PCR System (Applied Biosystems).
DNA Constructs and Luciferase Assay
The generation of the Firefly luciferase constructs was as described (Stern-Gi-
nossar et al., 2007). Mutations in MICB and MICA 30UTR were generated by
PCR extension of mutated complementary primers (see Supplemental Data)
using the DNA polymerase BIO-X-ACT long (BIO-21049 from BIOLINE). The
following primers were used (50 to 30): mut-K, CGTAGAGAGCCAGCAAAGGCT
TCATGACCAACTCAACATTCCATTGG; mut-E1, CCTGACCTATGAAACAGAA
ACCAACATCACTTATTTATTGTTGTTGG; mut-E2, CCAATAAATACGAAGGG
CTGTGGACCATCAGAGCCCTTGTTCACG; MICA to MICB, GTAATTCTAGAG
AAGAAAACATCAG. RKO and 293T cells, plated in 24-well plates, were
transfected with the LT1 transfection reagent (Mirus) with 100 ng of a Firefly
luciferase reporter vector and 5 ng of the control Renilla luciferase pRL-CMV
(Promega) at a final volume of 0.5 ml. Firefly and Renilla luciferase activities384 Cell Host & Microbe 5, 376–385, April 23, 2009 ª2009 Elsevier Iwere measured consecutively with the Dual-Luciferase Assay System (Prom-
ega) 48 hr after transfection. Firefly luciferase activity was normalized toRenilla
luciferase activity and then normalized to the average activity of the control
reporter.
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